THE IMPACT OF INTRAOCULAR PRESSURE ON RETINAL NERVE FIBER LAYER THICKNESS: A COMPREHENSIVE REVIEW
International Journal of Advanced Research · 31.05.2026 · 14 (05) · 1603-1608
DOI: 10.21474/ijar01/23565 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Research, online erschienen am 31.05.2026. Verfasst von Vibhanshu Gupta.
Abstract (Originalsprache)
Glaucoma, a major cause of blindness globally, is often treated by controlling and reducing eye pressure (IOP). This research examines the importance of IOP in the loss of thickness in the retinal nerve fiber layer RNFL. This review began with a search of the PubMed and Google Scholar databases. Peer-reviewed journal publications of clinical trials assessing the impact of IOP management on RNFL thickness were a prerequisite for inclusion. When no peer-reviewed articles were available, other publications from the conference proceeded. Elevated IOP is a major risk factor for injury to the RNFL. Both long-term and sudden IOP fluctuations contribute to RNFL loss. Studies have demonstrated that managing IOP helps preserve RNFL thickness and reduces glaucoma progression. For the prevention of vision loss and permanent damage, clinicians emphasize IOP control as the foundation of glaucoma management.
Zitieren
APA
Gupta, V. (2026). THE IMPACT OF INTRAOCULAR PRESSURE ON RETINAL NERVE FIBER LAYER THICKNESS: A COMPREHENSIVE REVIEW. International Journal of Advanced Research, 14(05), 1603-1608. https://doi.org/10.21474/ijar01/23565
Vancouver
Gupta V. THE IMPACT OF INTRAOCULAR PRESSURE ON RETINAL NERVE FIBER LAYER THICKNESS: A COMPREHENSIVE REVIEW. International Journal of Advanced Research. 2026;14(05):1603-1608. doi:10.21474/ijar01/23565
BibTeX
@article{Gupta2026,
author = {Gupta, Vibhanshu},
title = {THE IMPACT OF INTRAOCULAR PRESSURE ON RETINAL NERVE FIBER LAYER THICKNESS: A COMPREHENSIVE REVIEW},
journal = {International Journal of Advanced Research},
year = {2026},
volume = {14},
number = {05},
pages = {1603--1608},
doi = {10.21474/ijar01/23565}
}
EUVIMED